This is a routine governance filing with no trading implications. No action required. Monitor for any subsequent material announcements regarding pipeline progress or financial results.
Price Chart
Executive Summary
Alterity Therapeutics filed a Form 6-K with an Appendix 4G, a routine corporate governance disclosure required by the ASX for the financial year ended June 30, 2026. The filing confirms the company's corporate governance statement is available on its website and details compliance with ASX Corporate Governance Council recommendations. This is an administrative filing with no material financial or operational news, and no impact on the company's business outlook or stock price.
Key Facts
- Filed Appendix 4G (Key to Disclosures) for the financial year ended June 30, 2026.
- Corporate governance statement is available at https://alteritytx.com/governance/.
- Filing is a routine ASX compliance requirement with no financial data or business updates.
- No material changes to operations, financials, or strategy disclosed.
Financial Impact
No financial impact — filing is a governance compliance document with no financial figures.
Risk Factors
- No new risks identified from this filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001437749-26-029124 |
| Document: 0001437749-26-029124-index-headers.html | 0001437749-26-029124 |
| Document: 0001437749-26-029124-index.html | 0001437749-26-029124 |
| Document: 0001437749-26-029124.txt | 0001437749-26-029124 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 4d ago | 6-K | $2.09 | awaiting T+60 | — | $2.14 (−2.39%) |
Oct 23, 2026 4d ago | 6-K | $2.09 | awaiting T+60 | — | $2.14 (+2.39%) |
Oct 23, 2026 4d ago | 6-K | $2.09 | awaiting T+60 | — | $2.14 (+2.39%) |
Oct 21, 2026 6d ago | 6-K | $2.39 | awaiting T+60 | — | $2.14 (−10.46%) |
Oct 21, 2026 6d ago | 6-K | $2.39 | awaiting T+60 | — | $2.14 (−10.46%) |
Oct 19, 2026 8d ago | 6-K | $2.43 | awaiting T+60 | — | $2.14 (−11.93%) |
Oct 9, 2026 18d ago | 6-K | $3.12 | awaiting T+60 | — | $2.14 (−31.41%) |
Oct 5, 2026 22d ago | Press Release | $3.22 | awaiting T+60 | — | $2.14 (−33.54%) |
Oct 5, 2026 22d ago | 6-K | $3.22 | awaiting T+60 | — | $2.14 (−33.54%) |
Sep 25, 2026 4w ago | 6-K | $3.67 | awaiting T+60 | — | $2.14 (−41.69%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers